CCBC Stock UPDATES Chino Commercial Bcp (CCBC) 15.0500 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chino Commercial Bcp (CCBC) 15.0500 $CCBC

Chino Commercial Bancorp Reports 40% Increase in Second Quarter Earnings
PR Newswire - Mon Jul 21, 4:00AM CDT
The Board of Directors of Chino Commercial Bancorp ("CCBC" , the parent company of Chino Commercial Bank, N.A., announced the results of operations for the Bank and the consolidated holding company for the second quarter ended June 30, 2014 with net earnings of $363,551, or an increase of 40.3% compared with net income of $259,167 for the same quarter last year. Net income per basic and diluted share for the second quarter in 2014 was $0.44 as compared $0.31 for the same quarter last year. The Company's income for the six months ended June 30, 2014 increased 36.8% to $587,971, or $0.71 per basic and diluted share as compared with net income of $429,807 or $0.52 per basic and diluted share for the same period in 2013.

Chino Commercial Bank receives Highest Recognition from Bauer Financial Inc.
PR Newswire - Thu Feb 13, 4:52PM CST
Chino Commercial Bank, a wholly owned subsidiary of Chino Commercial Bancorp, was recognized by Bauer Financial with their highest rating of "5- Stars" for the most recent financial performance. Bauer Financial's rating system is based upon an analysis of current data as supplied by federal banking regulators, with the 5-Star rating indicating the Bank's solid capital position, profitability, sound asset quality, and balance sheet strength. According to Bauer Financial the recognition of 5-Star rating places the Bank among the strongest in the Nation.

Chino Commercial Bancorp Reports 59% Increase In Profits
PR Newswire - Wed Jan 22, 8:48PM CST
The Board of Directors of Chino Commercial Bancorp (OTC BB: CCBC), the parent company of Chino Commercial Bank NA, announced the results of operations for the Bank and the consolidated holding company for the three and twelve months ended December 31, 2013. For the full year ended December 31, 2013 the company posted a consolidated net income of $940,727, an increase of 59.5% over net income of $589,766 for the year ended December 31, 2012. Net income for the quarter ended December 31, 2013 increased 174.6% to $295,970 from $107,796 for quarter ended December 31, 2012. Net income per basic share and fully diluted share was $1.13 for the year ended December 31, 2013, a 54.8% increase over $0.73 per share for the year ended December 31, 2012. Earnings per basic share and diluted share for the fourth quarter ended December 31, 2013 were $0.36 as compared to $0.13 for the fourth quarter of 2012.

Weight Loss Surgery from BHP Leads to Incredible Results
PR Newswire - Tue Jan 21, 11:35AM CST
Throughout the U.S. and around the globe, obesity and excess weight are an increasingly serious issue. However, for those looking to undergo weight loss surgery in Rancho Cucamonga and other regions throughout Southern California, Beverly Hills Physicians serves as an invaluable resource. Every day, it seems, new research sheds light on the importance of losing weight for maintaining a healthy, happy lifestyle, and with treatments like gastric sleeve, lap band and many others, BHP patients can rest-assured they're receiving the best possible care. That's because every weight loss treatment offered at BHP, from the reversible lap band treatment to a complex lap band revision to gastric sleeve procedure, is performed safely and skillfully, ensuring the best possible results.

Chino Commercial Bancorp Reports 108.7% Increase In Second Quarter Earnings
PR Newswire - Mon Jul 22, 4:00AM CDT
The Board of Directors of Chino Commercial Bancorp ("CCBC" , the parent company of Chino Commercial Bank, N.A., announced the results of operations for the Bank and the consolidated holding company for the second quarter ended June 30, 2013 with net earnings of $259,167, or an increase of 108.7%, as compared with net income of $124,196 for the same quarter last year. Net income per basic and diluted share for the second quarter in 2013 was $0.31 as compared to $0.15 for the same quarter last year. The Company's profit for the six months ended June 30, 2013 increased 31.0% to $429,807 or $0.52 per basic and diluted share as compared with net earnings of $328,154 or $0.41 per basic and diluted share for the same period in 2012.

Chino Commercial Bancorp Reports 2013 First Quarter Earnings
PR Newswire - Mon Apr 22, 4:00AM CDT
The Board of Directors of Chino Commercial Bancorp (OTCBB: CCBC), the parent company of Chino Commercial Bank, N.A., announced the results of operations for the Bank and the consolidated holding company for the first quarter ended March 31, 2013 with net earnings of $170,640, or an increase of 58% over the previous quarter's earnings of $107,796, and a 19.2% reduction as compared with net income of $203,959 for the same quarter last year. Net income per basic share for the first quarter in 2013 was $0.21 as compared to $0.13 for the previous quarter ended December 31, 2012, and $0.26 for the same quarter last year.

Chino Commercial Bank Given Super Premier Performing Recognition
PR Newswire - Fri Apr 05, 3:51PM CDT
Chino Commercial Bank was recently recognized by The Findley Reports on Financial Institutions by receiving Findley's highest rating of "Super Premier Performing Bank" for the 2012 fiscal year. The Bank, which has branches in Chino, Ontario, and Rancho Cucamonga, received the recognition from Findley for its financial and operational performance during the 2012 year, including Profitability and Loan performance.

Chino Commercial Bancorp Announces Plan to Deregister Common Stock in Accordance With the JOBS Act
PR Newswire - Wed Jan 23, 4:00AM CST
Chino Commercial Bancorp (OTCBB: CCBC) the holding company for Chino Commercial Bank, announced today that the Board of Directors has approved the filing of a Form 15 with the Securities and Exchange Commission ("SEC" to voluntarily deregister its common stock under Section 12(g) of the Securities Exchange Act of 1934 ("the Exchange Act" pursuant to the provisions of the Jumpstart Our Business Startups Act (the "JOBS Act" . The Company filed a Form 15 on January 23, 2013 and expects it to become effective 90 days after filing, subject to certain additional SEC filings including that of an additional Form 15 under Section 15(d) of the Exchange Act. The Form 15 filing will allow the Company to suspend its periodic reporting obligations, including annual, quarterly and current reports on Forms 10-K, 10-Q and 8-K.

Chino Commercial Bancorp Reports 33.6% Increase In Profits
PR Newswire - Fri Jan 18, 4:00AM CST
The Board of Directors of Chino Commercial Bancorp (OTCBB:CCBC), the parent company of Chino Commercial Bank NA, announced the results of operations for the Bank and the consolidated holding company for the three and twelve months ended December 31, 2011. For the full year ended December 31, 2011 the company posted a consolidated net income of $589,766, an increase of 33.6% over net income of $441,401 for the year end 2011. Net income for the quarter ended December 31, 2012 decreased 35.8% to $107,796 from $167,928 for quarter ended December 31, 2011. Net income per basic share and fully diluted share was $0.72 for the year ended December 31, 2012 a 22.0% increase over $0.59 per share for the year ended December 31, 2011. Earnings basic share and diluted share for the fourth quarter ended December 31, 2012 were $0.13, as compared to $0.22 for the fourth quarter of 2011.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles